← All organizations
Highest phase reached
Phase 2
First clinical trial
Apr 1, 2005First marketed drug
Aug 15, 1997First NDA
Aug 15, 1997Last known activity
Mar 3, 2017
Timeline
1960s
- Jan 1, 1969
SmartPractice— Founded
1990s
- Aug 15, 1997
thin-layer rapid use epicutaneous patch test— NDA Organization
- Aug 15, 1997
thin-layer rapid use epicutaneous patch test— NDA Secondary Org
2000s
- Jan 1, 2008
Epitest— Acquired
Drugs by trial phase (4 distinct, 2 trials)
Phase 2 (4 own, 0 via acquisition)
Indications
Marketed drugs (1)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (3)
- NCT00133341Lead sponsorPhase 2Apr 1, 2005
- NCT00132600Overall official - principal investigatorPhase 2Apr 1, 2005
- NCT00132600Lead sponsorPhase 2Apr 1, 2005
Details
- Founded
- Phoenix, AZ, US Jan 1, 1969
- First NDA
- Aug 15, 1997
- Last known activity
- Mar 3, 2017